There was no significant difference of ABCA3 expression level in AML (median: 0.211; p=0.136), CML-BC (median: 0.174; p=0.097) and the different AML subtypes M2 (median: 0.242; p=0.215), M3 (median: 0.195; p = 0.186) and M5 (median: 0.221; p=0.364) in comparison with the HI group (median: 0.313). The gene discussed is ABCA3; the disease is breast cancer.